Re: Results from five new studies on Genomic Health's Oncotype DX breast cancer test
Yeah..well...would have gladly paid out of pocket to avoid recurrence. Joe, you would be amazed to see (in the session notes) how they thought I was paranoid over the her2 issue. I even brought up the her2 site and they said it was just a bunch of unrepresentative extreme cases.
|